MedTrace Logo

A Cohort Study on the Prognosis of Neonatal KCNQ2 Gene-associated Epileptic Encephalopathy

NCT03934268 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-09-21

No results posted yet for this study

Summary

The researchers hope to explore the etiological distribution and influencing factors of KCNQ2-related neonatal convulsions or refractory epileptic encephalopathy, and to improve the level of assessment, identification, intervention and shunt of KCNQ2-related convulsions. To formulate countermeasures and measures for prevention, management and health education.

Conditions

  • Seizures
  • Seizure Disorder
  • Seizure Newborn
  • Seizures, Generalized
  • Epileptic Encephalopathy
  • Epileptic Encephalopathy, Neonatal-onset
  • Epileptic Encephalopathy, Infant-onset
  • KCNQ2

Interventions

GENETIC

KCNQ2

The researchers extracted DNA from the baby's serum and sent it to WES to get the baby's total exon sequence.

Sponsors & Collaborators

  • Children's Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Wenhao Zhou, Prof. · Children Hospital of Fudan University

Eligibility

Min Age
0 Days
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03934268 on ClinicalTrials.gov